BRIEF published on 09/23/2026 at 08:25, 1 month 17 days ago ViferaXS Secures €12 Million for Cancer Trial and Pipeline Expansion Clinical Trials Oncology Pipeline Cancer Immunotherapy Biotechnology Investment ViferaXS Funding
PRESS RELEASE published on 09/23/2026 at 08:20, 1 month 17 days ago ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline ViferaXS raises €12 million for Phase II trial in Chronic Lymphocytic Leukemia, advancing peptide-based cancer immunotherapy. SPRIND and Huma lead funding round Phase II Trial Cancer Immunotherapy €12 Million ViferaXS Chronic Lymphocytic Leukemia
Published on 11/11/2026 at 03:30, 3 hours 5 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 5 hours 55 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 7 hours 5 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 7 hours 35 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 7 hours 35 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 03:25, 3 hours 10 minutes ago Experts Gather in Nanjing to Explore the Cultural Heritage of the Yangtze River
Published on 11/11/2026 at 00:15, 6 hours 20 minutes ago Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 7 hours 20 minutes ago GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 17:31, 13 hours 4 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 16 hours 35 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 19 hours 33 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 23 hours 35 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 12 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
